BBC

Fund Description
Virtus LifeSci Biotech Clinical Trials ETF is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the performance of the LifeSci Biotechnology Clinical Trials Index. Clinical Trials stage companies are typically younger, smaller companies which do not have a drug approved, but instead focus on testing their experimental drugs.
Fund Profile
Fund Name Virtus LifeSci Biotech Clinical Trials ETF
Fund Exchange Ticker BBC
Fund Sponsor Virtus ETF Solutions
Fund ISIN US26923G3011
Net Expense Ratio 0.79 %
Fund Inception Date 17 December 2014
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name LifeSci Biotechnology Clinical Trials Index
Index Provider LifeSci Index Partners
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 26 November 2021
Asset Under Management 34.56 Million (USD)
1 Month Total Return -6.93 %
Year To Date Return -18.01 %
1 Year Total Return -8.87 %
3 Year Annualized Total Return 14.41 %
NAV 40.66
Share Outstanding 850,004
Top 10 Holdings (26 November 2021)
Constituent Name Constituent Ticker Constituent Type Weighting
CHEMOCENTRYX INC CCXI EQUI 0.0189000000
IVERIC BIO INC ISEE EQUI 0.0163000000
CEREVEL THERAPEUTICS HOLDING CERE EQUI 0.0158000000
Arcus Biosciences Inc RCUS EQUI 0.0126000000
BNY MELLON CASH RESERVE USD MMKT 0.0122000000
CYTOKINETICS INC CYTK EQUI 0.0120000000
Bicycle Therapeutics PLC BCYC EQUI 0.0118000000
DYNAVAX TECHNOLOGIES CORP DVAX EQUI 0.0116000000
INHIBRX INC INBX EQUI 0.0109000000
CODEXIS INC CDXS EQUI 0.0108000000